dexamethasone
dexamethasone is listed in the FDA National Drug Code directory with 24 NDC codes, marketed under brand names including dexamethasone, Dexycu, Dexamethasone. Available dosage forms: tablet, injection, suspension, implant, insert, powder.
Drug Details
- Generic Name
- dexamethasone
- Brand Names
- dexamethasone, Dexycu, Dexamethasone, MAXIDEX, DEXTENZA, Hemady, OZURDEX
- Application Number
- ANDA216295
- Sponsor
- Major Pharmaceuticals
- NDC Codes
- 24
- Dosage Forms
- TABLET, INJECTION, SUSPENSION, IMPLANT, INSERT, POWDER, FOR SUSPENSION
- Routes
- ORAL, INTRAOCULAR, OPHTHALMIC, INTRACANALICULAR, INTRAVITREAL
- Active Ingredients
- DEXAMETHASONE
Indications and Usage
1 INDICATIONS AND USAGE OZURDEX is a corticosteroid indicated for: The treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) ( 1.1 ) The treatment of non-infectious uveitis affecting the posterior segment of the eye ( 1.2 ) The treatment of diabetic macular edema ( 1.3 ) 1.1 Retinal Vein Occlusion OZURDEX ® (dexamethasone intravitreal implant) is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). 1.2 Posterior Segment Uveitis OZURDEX is indicated for the treatment of non-infectious uveitis affecting the posterior segment of the eye. 1.3 Diabetic Macular Edema OZURDEX is indicated for the treatment of diabetic macular edema.